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The determination of my@inositol t&phosphate by an enzymatic fluorometric assay is 
presented. The method involves the acid extraction of water-soluble inositol polyphosphates 
followed by separation by anion-exchange chromatography. Samples are subsequently neutral- 
ized by passage over a Dowex c1- resin and elution with lithium chloride. Samples are then 
desalted with ethanol. Following dephosphorylation with alkaline phosphatase, free my&nosi- 
to1 is measured enxymatically via the NAD-dependent oxidation to scy1/&nosose with myo- 
inositol dehydrogenase. The efficiency of recovery, assay specificity, and an application to the 
measurement of inositol polyphosphates in hormone-stimulated tissue are discussed. 8 1987 
Academic F’ms, Inc. 
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The hydrolysis of phosphatidylinositol 
4,Sbisphosphate with the formation of free 
inositol polyphosphates is now regarded as 
an important step in signal transduction with 
calcium-mobilizing effecters (l-3). Specifi- 
cally, inositol 1,4,5&isphosphate has been 
demonstrated to mobilize calcium from in- 
tracellular stores (4-6). 
The study of effector-induced phosphati- 
dylinositol metabolism, however, has been 
largely limited to radiotracer studies. In these 
reports the elaboration of inositol polyphos- 
phates is determined by changes in the activ- 
ity of [3H]inositol-containing metabolites 
(often in the presence of lithium chloride to 
inhibit inositol 1 -phosphatase activity). Al- 
ternatively, changes in inositol phosphates 
are inferentially determined by changes in 
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the activity of 32P-containing phospholipids 
(7) or by comparison to other phosphate- 
containing metabolites (8). The former tech- 
nique is limited to those tissues which are 
able to incorporate [3H]inositol; such studies 
usually assume that all [3H]inositol-contain- 
ing metabolites are at equal specific activity. 
This assumption has not been tested. The 
latter technique does not provide specific 
data on the individual inositol phosphates 
formed. 
A practical method for determining inosi- 
to1 polyphosphate mass would therefore be 
useful. MacGregor and Matschinsky (9) have 
developed a sensitive enzymatic assay for the 
determination of myo-inositol mass. This 
method has been modified and utilized for 
the determination of inositol trisphosphate 
mass. 
METHODS 
Principles of the assay. The quantitative 
determination of inositol trisphosphate uti- 
lizes a multistep assay. It is based upon the 
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separation of IPj3 by anion-exchange chro- 
matography, dephosphorylation, and fluoro- 
metric enzymatic determination of the free 
inositol. Specifically, this involves eight dis- 
tinct steps: 
(1) Biological samples are extracted with 
trichloroacetic acid and neutralized by ex- 
traction of the trichloroacetic acid with 
diethyl ether. 
(2) IP,, IP2, and IP3 are separated by 
anion-exchange chromatography on a 
Dowex formate resin and a stepwise elution 
with an ammonium formate and formic acid 
gradient. 
(3) To remove the ammonium formate 
and formic acid, the separated IP3 is added to 
a second anion-exchange resin and eluted 
with 1.5 M lithium chloride. The sample is 
dried and most of the lithium chloride is re- 
moved with anhydrous ethanol. The lith- 
ium-IP3 salt is insoluble in ethanol. 
(4) IP3 is dephosphorylated with intestinal 
alkaline phosphatase forming free myo-ino- 
sitol. 
(5) Free myo-inositol is converted to 2- 
scyllo-inosose with the myo-inositol dehy- 
drogenase. The reaction is pulled to comple- 
tion with malate dehydrogenase: 
myo-inositolm2-scyilo-inosose 
NAD+ NADH NAD’ 
oxaloacetate umalate 
(6) The NADH and oxaloacetate are de- 
stroyed and the malate is converted back to 
oxaloacetate with malate dehydrogenase, 
yielding a stoichiometric amount of NADH. 
This reaction is pulled to completion with 
glutamate and aspartate transaminase: 
glutamate X cr-ketoglutarate malate*oxaloacetate aspartate 
NAD+ NADH 
’ Abbreviations used: IP,, myo-inositol monophos- 
phate; IP2, my&nositol bisphosphate; IP3, myc+inositol 
t&phosphate. 
(7) To obtain the necessary sensitivity, the 
NADH formed is amplified with the enzy- 
matic cycling method of Kato et al. (lo), 
which utilizes alcohol dehydrogenase and 
malate dehydrogenase: 
oxaloacetate it+ malate 
NADH NAD+ 
acetaldehyde u ethanol 
(8) The malate formed is then deter- 
mined, coincidentally, by the same reactions 
as in step 6. 
A protocol suitable for measuring 1 to 10 
pmol of inositol trisphosphate and its appli- 
cation to primary cultures of renal papillary- 
collecting tubule cells are given below. This 
protocol, however, is also applicable to other 
biologic samples. 
Step 1: Renal cell c&we, hormonal stimu- 
lation, and sample extraction. Primary cul- 
tures of rabbit papillary-collecting tubule 
cells were harvested and grown as previously 
described (11). Cell cultures (0.5 to 2.0 X lo6 
cells per dish) were rinsed three times with 
Krebs buffer and stimulated at 37°C with 
buffer alone or with bradykinin (lo-’ M). In- 
cubations were terminated by the rapid aspi- 
ration of buffer followed by the addition of 1 
ml of ice-cold trichloroacetic acid (1 M). The 
precipitated protein and lipid were separated 
by centrifugation in an Eppendorf 54 14 cen- 
trifuge. Protein was determined with the 
fluorescamine reagent ( 12). Aliquots (500 ~1) 
of supernatant from the trichloroacetic acid- 
treated samples were placed in 13 X loo-mm 
test tubes and extacted with 2 ml of water- 
saturated diethyl ether. This extraction was 
repeated four times. The residual ether was 
evaporated by heating the samples to 65°C 
for 15 min. The remaining traces of trichlo- 
roacetic acid in the ether-extracted samples 
were neutralized with 1 M sodium bicarbon- 
ate (120 ~1 for a 5OO-j,d sample). 
Step 2: Chromatographic separation. The 
entire sample was applied to a 0.75 X 12-cm 
column containing Dowex AG 1 - x8 formate 
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form, anion-exchange resin (bed volume 1 
ml) (Bio-Rad, Richmond, CA). Inositol and 
the inositol phosphates were serially eluted 
with (a) water 4 ml 4X; (b) 0.025 M ammo- 
nium formate 4 ml 2X; (c) 0.2 M ammonium 
formate, 0.1 M formic acid 4 ml 2X; (d) 0.4 M 
ammonium formate, 0.1 M formic acid 4 ml 
2X; and (e) 0.75 M ammonium formate, 0.1 
M formic acid 4 ml 2X. These solvents 
eluted, respectively, inositol, glycerophos- 
phatidyl inositol, IP1, IP2, and IP,. The suc- 
cess of this separation procedure has been 
reported by previous investigators ( 13). Posi- 
tional isomers of the inositol phosphates, 
however, were not separated. A reduced 
concentration of ammonium formate was 
utilized in (e) so as not to include inositol 
tetrakisphosphate in the IPs fraction (14). 
Step 3: Desalting and neutralizing. Sepa- 
rated samples were desalted and neutralized 
by an adaptation of a recently reported pro- 
tocol (15). Samples were diluted with 50 ml 
of water and added to a second anion-ex- 
change column (Dowex AG l- x8, 200-400 
mesh, chloride form, column size 0.75 X 12 
cm, bed volume 2 ml). The column was fur- 
ther washed with an additional 25 ml of 
water. The inositol phosphates were then 
eluted with 8 ml of 1.5 M LiCl. Samples were 
brought to dryness in a vacuum centrifuge 
(Speed Vat, Savant). Trapped water was re- 
moved by resuspension of the lithium salts in 
4 ml of anhydrous ethanol and reevapora- 
tion. This was repeated three times. The 
dried pellet was resuspended in 8 ml of abso- 
lute ethanol. The remaining lithium chloride 
containing the insoluble lithium phosphate 
salts was pelleted by centrifugation at 4000g 
(Beckman 52-21 centrifuge). The superna- 
tant was then removed. This procedure was 
repeated three times or until only a small 
pellet, barely visible, remained. Samples 
were then evaporated to dryness. 
Step 4: Dephosphorylation of inositol poly- 
phosphates. Samples were reconstituted in 
50 ~1 of Tris buffer (50 mM, pH 9.0) contain- 
ing 50 U/ml of bovine intestinal alkaline 
phosphatase and 5 mM MgCIZ and were in- 
cubated for 2 h at 37°C. The alkaline phos- 
phatase was reconstituted in 20 mM imidaz- 
ole-HCl buffer (pH 7) containing 0.02% al- 
bumin before its addition to the Tris buffer. 
The alkaline phosphatase was then inacti- 
vated by heating the samples for 3 min in a 
boiling water bath. 
Step 5: myo-Inositol oxidation. Initial 
steps were performed in 6 X 50-mm borosili- 
cate, nitric acid-washed tubes. All enzymes 
suspended in ammonium sulfate were pel- 
leted by centrifugation and resuspended in 
imidazole-HCl buffer (pH 7.0), containing 
0.02% bovine serum albumin. An exception 
was myo-inositol dehydrogenase; this en- 
zyme was reconstituted in 0.02 M potassium 
phosphate buffer, pH 7.0 (see Results and 
Discussion). 
myo-Inositol dehydrogenase reagent (2 ~1) 
was added to a lo-p1 aliquot of sample from 
step 4. This reagent consisted of Tris-HCl 
buffer (350 mM, pH 9.0), oxaloacetate (7 
mM), malate dehydrogenase (15 U/ml), 
NAD+ (1.5 mM), and myo-inositol dehy- 
drogenase (1 .O U/ml). After incubating at 
25 “C for 40 min, excess oxaloacetate was de- 
stroyed by adding 0.5 ~1 of 13 mM Hz02 and 
heating in a water bath at 75°C for 20 min. 
Step 6: Malate oxidation. NADH was gen- 
erated next by the oxidation of malate to ox- 
aloacetate with 10 ~1 of malate dehydroge- 
nase reagent. This consisted of 2-amino 2- 
methyl I-propanol-HCl buffer (200 mM, pH 
9.9) containing malate dehydrogenase (35 
U/ml), glutamate (50 mM), glutamic oxalo- 
acetic transaminase (5 U/ml), and catalase 
(2000 U/ml). To permit the amplification of 
the NADH formed by enzymatic cycling, the 
excess NAD+ was destroyed by adding 5 cl1 
of NaOH (0.35 N) and heating for 20 min 
at 75°C. 
Step 7: Amplijcation. The cycling of 
NADH was performed with the method of 
Kato et al. (10). The enzyme concentrations 
were adjusted to cycle 1000 times. Cycling 
was performed on 5 ~1 of the 27.5+1 incuba- 
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PIG. I. Standard curve for my+inositol determina- 
tion. The points represent the means of triplicate sam- 
ples. 
tion mixture. Samples were cycled in 10 
X 75-mm borosilicate tubes with 100 ~1 of 
cycling reagent. This reagent was added to 
samples while on ice and within a 5-min time 
span. The rack of samples was then incu- 
bated for 1 h in a 25°C water bath, and cy- 
cling was terminated by heating for 3 min in 
a boiling water bath. 
The assay was completed by measuring the 
malate formed during cycling with a reagent 
consisting of 2-amino 2-methyl 1 -propanol 
buffer (pH 9.9, 50 mM), malate dehydroge- 
nase (5 U/ml), glutamate (10 mM), glutamic 
oxaloacetic transaminase (2 U/ml), and 
NAD (200 PM). One milliliter of this reagent 
was added to the cycled samples. Fluores- 
cence was determined in a Farrand filter flu- 
orometer following a 20-min incubation 
at 25°C. 
Calculations were based on a standard 
curve for myo-inositol (l-10 pmol) intro- 
duced at step 5. This is depicted in Fig. 1. 
Recoveries of IPa were assessed either by par- 
allel determinations of known quantities of 
authentic JP3, assayed following exposure to 
trichloroacetic acid, or by spiking samples 
with [3H]IP3 at step 1. The observed recover- 
ies for the overall determination of IPX and 
for the individual steps are discussed below. 
Materials. Biochemicals, including en- 
zymes, were purchased from Sigma Chemi- 
cal Co. (St. Louis, MO) with the following 
exceptions. Inositol 1 $bisphosphate was the 
generous gift of Dr. William Sherman 
(Washington University Medical School, St. 
Louis, MO). Malate dehydrogenase and cat- 
alase were obtained from Boehringer-Mann- 
heim (Indianapolis, IN). myo-[2-‘H]Ino- 
sit01 1,4,5-trisphosphate was purchased from 
Amersham (Niles, IL). Inositol 1,2-cyclic 
monophosphate was synthesized by the 
method of Pfizer and Ballou (16) as pre- 
viously described ( 17). 
RESULTS AND DISCUSSION 
Recovery. The separation of IPi, IP2, and 
IP3 by anion-exchange chromatography was 
confirmed by the addition of authentic ino- 
sit01 phosphate standards to columns con- 
taining Dowex formate resin and by the de- 
termination of myo-inositol mass following 
desalting and dephosphorylation. myo-Inosi- 
to1 could be detected only in fractions eluting 
with 0.2 M ammonium formate, 0.1 M for- 
mic acid for IP, ; 0.4 M ammonium formate, 
0.1 M formic acid for IPZ; and 0.75 M ammo- 
nium formate, 0.1 M formic acid for IP3. The 
recovery of authentic IP3 added to 1 M tri- 
chloroacetic acid and chemically measured 
by the eight-step assay varied between 75 and 
95%. These measurements were performed 
on either 100 pmol or 1 nmol of IP3 in du- 
plicate during three separate determinations. 
When the recovery of authentic standard 
was assessed at each step, it was determined 
that the greatest loss occurred during the re- 
moval of the LiCl (step 3). Whereas greater 
than 95% of [3H]IP3 added to the Dowex 
chloride column at step 2 could be recovered 
by LiCl elution, only 70 to 95% of the labeled 
standard remained in the pellet following 
ethanol extraction. Losses at this step were 
even more substantial if care was not taken 
to remove trapped water prior to LiCl re- 
moval. This problem could possibly be less- 
ened by eluting IP3 with LiCl at a lower con- 
centration. However, the recovery of [3H]IP3 
from the Dowex chloride column was sub- 
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stantially lower when 1 .O M LiCl or less was 
used. The recovery of 100 pmol of IP3 was 
the smallest amount assessed. For assay of 
smaller amounts of IP3, recovery would need 
to be determined. 
The recovery of [3H]IP3 from the Dowex 
formate column (step 2) and following de- 
phosphorylation (step 4) was greater than 
98%. The recovery of authentic unlabeled 
inositol as determined by the enzymatic fluo- 
rometric assay (steps 5 through 8) was greater 
than 95% and was determined with samples 
as small as 1 pmol. 
Dephosphorylation. The concentration de- 
pendence of dephosphorylation with alkaline 
phosphatase is shown in Fig. 2. Here, [3H]IP3 
was subjected to alkaline phosphatase hy- 
drolysis over a wide range of enzyme con- 
centrations. Following a 2-h incubation, 
samples were separated by anion-exchange 
chromatography. The formation of IPi, IP2, 
and IP3 was assessed by counting the samples 
eluting with each buffer. The results indicate 
that the rates of hydrolysis are very different 
for the successive compounds. The curves 
are consistent with removal of the frrst phos- 
phate at a (first-order) rate of 50% per hour 
with about 0.5 U/ml of enzyme, removal of 
the second phosphate at a tenth this rate 
(50% per hour with about 5 U/ml), and re- 
moval of the last phosphate at a rate inter- 
mediate between the two. These data are 
probably indicative of the inefficiency of hy- 
drolysis of vicinal phosphates by alkaline 
phosphatase. Similar observations have been 
reported previously for glycerophosphatidyl- 
inositides (15). 
myo-Inositol determination. The fluoro- 
metric measurement of myo-inositol follows 
the protocol of MacGregor and Matschinsky 
(9) with some modifications. First, the initial 
oxidation of malate (step 6) is performed 
without the addition of NAD+. Under the 
conditions employed for oxaloacetate de- 
struction, sufficient NAD+ remains from the 
inositol oxidation step (step 5) to allow for 
the complete oxidation of malate. 
A second change included the use of a 
lower concentration of oxaloacetate during 
the myo-inositol oxidation step. 
It was observed that if myo-inositol dehy- 
drogenase was dissolved in Tris buffer (pH 
8.1 or 9.0) or in 2-amino 2-methyl l-pro- 
panol (pH 9.9), the oxidative activity was 
lost. If instead the enzyme was reconstituted 
1 :[*J2Jo _‘;~o 
C 
ALKALI NE PHOSPHATASE U/d 
FIG. 2. The dephosphorylation of [‘H]IP, as a function of bovine intestinal alkaline phosphatase 
concentration. [‘H]IP3 (5 &i) was subjected to alkaline phosphatase digestion as described in the text. 
Samples were then separated by anion-exchange chromatography. The data are expressed as the percent- 
age of total ions. Quotation marks denote the fact that the precise structures of these compounds are 
unknown. Each point represents the mean of three. experiments. 
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TABLE 1 
OXIDATION OF INOSITOL PHOSPHATES BY 
TNJQ-INOSITOL DEHYDROGENASE 
Inositol 100 
Inositol 1 ,Zcyclic phosphate 0 
Inositol2-monophosphate 3 
Inositol 1,4-bisphosphate 0 
Inositol 1,4,5&sphosphate 0 
Note. Data are expressed as the percentage of expected 
malate production from the oxidation of inositol and 
inositol phosphates by myo-inositol dehydrogenase. 
in 0.02 M potassium phosphate buffer (pH 
7.0), then oxidative activity was preserved. 
Previous reports have detailed the speci- 
ficity of myo-inositol dehydrogenase for 
other sugars and sugar alcohols (9). Of the 
sugars tested, only glucose demonstrated sig- 
nificant reactivity. This is not problematic in 
the presently detailed method since glucose 
elutes with free myo-inositol in the chro- 
matographic system employed. myo-Inositol 
dehydrogenase appears to be completely in- 
active toward the inositol phosphates (Table 
1). The small amount of reactivity with IPi 
probably reflects contamination with myo- 
inositol. 
Inositol trisphosphate measurements in 
renal cells. Preliminary determinations of IP3 
mass were made in a biological system where 
radiolabeled IP3 has been demonstrated to 
increase in response to a polypeptide hor- 
mone. Specifically, when exposed to brady- 
kinin, rabbit renal papillary-collecting tubule 
cells exhibit increased radiolabeling of IP, 
with parallel changes in intracellular calcium 
mobilization and prostaglandin E2 forma- 
tion (11,18). 
Cells were incubated with or without bra- 
dykinin (lo-’ M) for 10 s. Duplicate samples 
were measured in four separate experiments. 
Tissue blanks omitting myo-inositol dehy- 
drogenase were 20 to 30% of the total ob- 
served fluorescence. Under these conditions, 
IPj rose from 0.16 + 0.05 to 0.34 f 0.08 
pmol/pg protein (p < 0.05 by paired t analy- 
sis). When intracellular volume was mea- 
sured from the distribution of ‘Hz0 and 
[i4C]inulin, intracellular IP3 was found to 
rise from 7.5 pM under basal conditions to 16 
I.LM following bradykinin stimulation. 
IP3, a product of the phosphodiesteratic 
cleavage of phosphatidylinositol 4,5-bis- 
phosphate, is now regarded as a potentially 
important second messenger in the mobili- 
zation of intracellular calcium. However, few 
data presently exist to confirm whether en- 
dogenous levels of IP3 are of sufficient mag- 
nitude to account for the calcium release ob- 
served with the addition of exogenous IP3 
either to permeabilized cells or to intact cells 
via micropipets. The data detailed above are 
of comparable magnitude to similar obser- 
vations made in thrombin-stimulated plate- 
lets (19). Moreover, the observed concentra- 
tion of IP3 under kinin-stimulated condi- 
tions is close to the reported K,,, for the 
5-phosphatase which degrades IP3 to IP2 
(20,21). However, both the basal and stimu- 
lated values of IP, in renal cells are in excess 
of those concentrations demonstrated as nec- 
essary for the mobilization of intracellular 
calcium in permeabilized cells (4). On the 
one hand, this difference in concentration 
may reflect the failure to resolve myo-inosi- 
to1 1,4,5&sphosphate from the other inosi- 
to1 trisphosphate isomers under the separa- 
tion conditions employed in the present 
study. On the other hand, IP3 concentrations 
may be regulated in intact cells (e.g., by 
compartmentalization) in ways not apparent 
in permeabilized cells. 
In summary, a sensitive enzymatic fluoro- 
metric assay for the determination of inositol 
trisphosphate mass has been described. The 
application of this method should permit the 
chemical determination of myo-inositol tris- 
phosphate levels in freshly isolated samples, 
tissues not amenable to radiolabeling, and 
small samples. Moreover, by simultaneously 
measuring radiolabeling and mass, it should 
be possible to determine the true specific ac- 
tivity of radiolabeled inositol phosphates. In 
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this manner, a more precise determination of 
the kinetics of inositol phosphate formation 
and degradation will be possible. 
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